Antiepileptic drug combinations-Have newer agents altered clinical outcomes?

Epilepsy Research

Volumn 98, Issue 2-3, 2012, Pages 194-198

  Stephen, Linda J ^a   Forsyth, Murray ^a   Kelly, Kevin ^a   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drug; Combination; Epilepsy; Polytherapy; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE FREE INTERVAL; DRUG EFFICACY; EPILEPSY; FEMALE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84856458040     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.09.008     Document Type: Article

References (17)

1. Bialer M., White H.S. Key factors in the discovery and development of new antiepileptic drugs. Nat. Rev. 2010, 9:68-82.
2. Brodie M.J., Yuen A.W.C. Lamotrigine substitution study: evidence for synergism with sodium valproate?. Epilepsy Res. 1997, 26:423-432. 105 Study Group.
3. Brodie M.J. Antiepileptic drug therapy: the story so far. Seizure 2010, 19:650-655.
4. Brodie M.J., Sills G.J. Combining antiepileptic drugs - rational polytherapy?. Seizure 2011, 20:369-375.
5. Brodie M.J., Covanis A., Gil-Nagel A., Lerche H., Perucca E., Sills G.J., White H.S. Antiepileptic drug therapy: does mechanism of action matter?. Epilepsy Behav. 2011, 21:331-341.
6. Deckers C.L., Hekster Y.A., Keyser A., Meinardi H., Renier W.O. Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 1997, 38:570.
7. Deckers C.L., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000, 41:1364-1374.
8. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342:314-319.
9. Löscher W., Schmidt D. Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma. Epilepsia 2011, 52:657-678.
10. Mohanraj R., Brodie M.J. Pharmacological outcomes in newly diagnosed epilepsy. Seizure 2005, 6:382-387.
11. Patsalos P., Berry D.J., Bourgeois B.F., et al. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008, 49:1239-1276.
12. Pisani F., Oteri G., Russo M.F., Di Perri R., Perucca E., Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 1999, 40:1141-1146.
13. Sander J.W. The epidemiology of epilepsy revisited. Curr. Opin. Neurol. 2003, 16:165-170.
14. Schmidt D., Löscher W. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 2005, 46:858-877.
15. Stephen L.J., Brodie M.J. Seizure freedom with more than one antiepileptic drug. Seizure 2002, 11:349-351.
16. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011. http://www.whocc.no/atc_ddd_index/.
17. Wilby J., Kainth A., Hawkins N., et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol. Assess. 2005, 9:1-157. iii-iv.